ADM Therapeutics
Adocia SAS
Eli Lilly and Co
Gubra ApS
Intarcia Therapeutics Inc
Neurimmune Holding AG
Nordic Bioscience AS
ProMIS Neurosciences Inc
reMYND NV
Wren Therapeutics Ltd
Zealand Pharma AS
Published | Pages | Publisher | Report code |
---|---|---|---|
Feb 2022 | 62 | Global Markets Direct | ASDR-597970 |
ADM Therapeutics
Adocia SAS
Eli Lilly and Co
Gubra ApS
Intarcia Therapeutics Inc
Neurimmune Holding AG
Nordic Bioscience AS
ProMIS Neurosciences Inc
reMYND NV
Wren Therapeutics Ltd
Zealand Pharma AS